224 related articles for article (PubMed ID: 2668333)
1. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
Nuijens JH; Eerenberg-Belmer AJ; Huijbregts CC; Schreuder WO; Felt-Bersma RJ; Abbink JJ; Thijs LG; Hack CE
J Clin Invest; 1989 Aug; 84(2):443-50. PubMed ID: 2668333
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
[TBL] [Abstract][Full Text] [Related]
3. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG
Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367
[TBL] [Abstract][Full Text] [Related]
4. [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].
Zeerleder S; Caliezi C; Redondo M; Devay J; Wuillemin WA
Schweiz Med Wochenschr; 1999 Oct; 129(39):1410-7. PubMed ID: 10542999
[TBL] [Abstract][Full Text] [Related]
5. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
[TBL] [Abstract][Full Text] [Related]
7. C1 inhibitor level on neonatal sepsis and its relations with clinical findings.
Tapisiz A; Ergenekon E; Oktem M; Koc E; Okumus N; Zenciroğlu A; Atalay Y
J Paediatr Child Health; 2010 Mar; 46(3):121-4. PubMed ID: 20180898
[TBL] [Abstract][Full Text] [Related]
8. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
Caliezi C; Wuillemin WA; Zeerleder S; Redondo M; Eisele B; Hack CE
Pharmacol Rev; 2000 Mar; 52(1):91-112. PubMed ID: 10699156
[TBL] [Abstract][Full Text] [Related]
9. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Abbink JJ; Strack van Schijndel RJ; Felt-Bersma RJ; Thijs LG; Hack CE
Blood; 1988 Dec; 72(6):1841-8. PubMed ID: 3264190
[TBL] [Abstract][Full Text] [Related]
10. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
[TBL] [Abstract][Full Text] [Related]
11. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
Alsenz J; Loos M
Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
14. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.
Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG
Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997
[TBL] [Abstract][Full Text] [Related]
15. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
16. [Functional determination of C1-inhibitor in plasma with a low level of prekallikrein].
Simonianová E; Tomásová H; Zoban P; Mydlilová A
Cas Lek Cesk; 1994 Oct; 133(20):638-40. PubMed ID: 7954679
[TBL] [Abstract][Full Text] [Related]
17. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
Martínez-Brotóns F; Oncins JR; Mestres J; Amargós V; Reynaldo C
Thromb Haemost; 1987 Aug; 58(2):709-13. PubMed ID: 3672421
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the proteolytic activity of mouse nerve growth factor by human C1(activated)-inhibitor.
Faulmann EL; Young M; Boyle MD
J Immunol; 1987 Jun; 138(12):4336-40. PubMed ID: 3295045
[TBL] [Abstract][Full Text] [Related]
19. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
20. [C1-inhibitor plasma levels in neonates and mothers during labor].
Simonianová E; Tomásová H; Mydlilová A; Zoban P
Cesk Pediatr; 1993 Dec; 48(12):707-10. PubMed ID: 8137443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
